P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome

MLA

Theodoros P. Vassilakopoulos, et al. “P114: Very Late Relapses in Patients with Hodgkin Lymphoma Occuring ≥5 Years after Initial Treament with Chemotherapy ± Radiotherapy: Treatment Strategies and Prognostic Factors for the Outcome.” HemaSphere, vol. 6, Oct. 2022, p. 53. EBSCOhost, https://doi.org/10.1097/01.HS9.0000891024.63916.91.

APA

Theodoros P. Vassilakopoulos, Athanasios Liaskas, Giuliana Rizzuto, Argyrios Symeonidis, Marzia Palma, Maria K. Angelopoulou, Chara Giatra, Flora Kondopidou, Maria Dimou, Alberto Musseti, Ioanna Xagoraris, Marina Siakantaris, Evgenia Verigou, Fotios Panitsas, John Asimakopoulos, Maria Arapaki, Chrysovalantou Chatzidimitriou, Marina Belia, Sotirios Sachanas, … Simonetta Viviani. (2022). P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome. HemaSphere, 6, 53. https://doi.org/10.1097/01.HS9.0000891024.63916.91

Chicago

Theodoros P. Vassilakopoulos, Athanasios Liaskas, Giuliana Rizzuto, Argyrios Symeonidis, Marzia Palma, Maria K. Angelopoulou, Chara Giatra, et al. 2022. “P114: Very Late Relapses in Patients with Hodgkin Lymphoma Occuring ≥5 Years after Initial Treament with Chemotherapy ± Radiotherapy: Treatment Strategies and Prognostic Factors for the Outcome.” HemaSphere 6 (October): 53. doi:10.1097/01.HS9.0000891024.63916.91.